Skip to main content

First Atrium C-Qur Mesh Trial Rescheduled For July 7, 2021

First Atrium C-Qur Mesh Trial Rescheduled For July 7, 2021

First Atrium C-Qur Mesh Trial Rescheduled For July 7, 2021

Introduction

U.S. District Judge Landya McCafferty of the United States District Court for the District of New Hampshire, overseeing all Atrium C-Qur hernia mesh lawsuits, rescheduled the first bellwether trial of the multidistrict litigation (MDL) to begin on July 7, 2021.

The proposal was sent in last week through a joint agenda by the parties involved in the litigation, indicating that they are optimistic that the case will proceed in-person before a jury. The parties also noted that they will revisit the logistics if the in-person trial becomes unmanageable.

The trial was initially scheduled for May 2020 but due to the on-going COVID-19 pandemic, the trial was delayed several times.

The result of this trial and other upcoming trials will not hold an obligation on other cases and will be closely monitored by the parties as it would influence settlements for the plaintiffs, helping avoid the need for individual trials nationwide in the coming years.

Currently, more than 2,500 hernia mesh lawsuits are pending against Atrium in the federal court system, each raising similar allegations that the C-Qur mesh has design defects and was unreasonably dangerous, and increased the need for additional corrective surgeries to remove or replace the patch.

Apart from Atrium C-Qur, other products, which include Ethicon Physiomesh, Bard Polypropylene Mesh, and Kugel Patches have also been alleged to cause similar complications.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

DOJ Opposes JnJ’s Texas Bankruptcy Move in Talc Lawsuit Cases

Categories: Talcum

The U.S. Department of Justice (DOJ) recently opposed Johnson & Johnson’s latest attempt to use bankruptcy to resolve tens of thousands of…

First Valsartan Bellwether Trial to Focus on Cancer Lawsuits

Categories: Valsartan

The U.S. District Judge overseeing…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!